메뉴 건너뛰기




Volumn 12, Issue 9, 2015, Pages

The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost–Benefit Analysis

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; PREVALENCE; SOUTH AFRICA; TREATMENT OUTCOME; VIRUS LOAD; ABSENTEEISM; ECONOMIC MODEL; ECONOMICS; HIV INFECTIONS; INCIDENCE; MALE; MARKOV CHAIN; MINING; OCCUPATIONAL HEALTH SERVICE; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 84943139179     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001869     Document Type: Article
Times cited : (11)

References (64)
  • 3
    • 34547663196 scopus 로고    scopus 로고
    • The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research
    • Rosen S, Feeley F, Connelly P, Simon J, The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research. AIDS. 2007;21 Suppl 3:S41–S51. 17666961
    • (2007) AIDS , vol.21 , pp. S41-S51
    • Rosen, S.1    Feeley, F.2    Connelly, P.3    Simon, J.4
  • 4
    • 77955439012 scopus 로고    scopus 로고
    • ‘HIV/AIDS is our business’: the moral economy of treatment in a transnational mining company
    • Rajak D, ‘HIV/AIDS is our business’: the moral economy of treatment in a transnational mining company. J R Anthropol Inst. 2010;16:551–571.
    • (2010) J R Anthropol Inst , vol.16 , pp. 551-571
    • Rajak, D.1
  • 5
    • 34547661905 scopus 로고    scopus 로고
    • Business and HIV/AIDS: the case of Anglo American
    • Brink B, Pienaar J, Business and HIV/AIDS: the case of Anglo American. AIDS. 2007;21 Suppl 3:S79–S84. 17666965
    • (2007) AIDS , vol.21 , pp. S79-S84
    • Brink, B.1    Pienaar, J.2
  • 6
    • 33745278308 scopus 로고    scopus 로고
    • Impact of HIV/AIDS and options for intervention: results of a five company pilot study
    • Greener R. Impact of HIV/AIDS and options for intervention: results of a five company pilot study. Working Paper No. 10. Gaborone: Botswana Institute of Development Policy Analysis; 1997.
    • (1997) , vol.10
    • Greener, R.1
  • 7
    • 84943181581 scopus 로고    scopus 로고
    • Feeley F, Bukuluki P, Collier A, Fox M, The impact of HIV/AIDS on productivity and labor costs in two Ugandan corporations. Boston: Center for International Health and Development, Boston University; 2004.
    • (2004)
    • Feeley, F.1    Bukuluki, P.2    Collier, A.3    Fox, M.4
  • 8
    • 84943186040 scopus 로고
    • AIDS Control and Prevention ProjectPrivate sector AIDS policy: African workplace profiles. Washington (District of Columbia): Family Health International; 1995.
    • (1995)
  • 10
    • 84943188727 scopus 로고    scopus 로고
    • Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva: Joint United Nations Programme on HIV/AIDS; 2013.
    • (2013) , vol.2013
  • 13
    • 1442354234 scopus 로고    scopus 로고
    • Prevalence of HIV in workforces in southern Africa, 2000–2001
    • Evian C, Fox M, MacLeod B, Slotow S, Rosen S, Prevalence of HIV in workforces in southern Africa, 2000–2001. S Afr Med J. 2004;94:125–130. 15034992
    • (2004) S Afr Med J , vol.94 , pp. 125-130
    • Evian, C.1    Fox, M.2    MacLeod, B.3    Slotow, S.4    Rosen, S.5
  • 14
    • 34347335670 scopus 로고    scopus 로고
    • The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients
    • Harling G, Wood R, The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients. J Acquir Immune Defic Syndr. 2007;45:348–354.
    • (2007) J Acquir Immune Defic Syndr , vol.45 , pp. 348-354
    • Harling, G.1    Wood, R.2
  • 15
    • 34447646498 scopus 로고    scopus 로고
    • Cost to patients of obtaining treatment for HIV/AIDS in South Africa
    • Rosen S, Ketlhapile M, Sanne I, Bachman DeSilva M, Cost to patients of obtaining treatment for HIV/AIDS in South Africa. S Afr Med J. 2007;97:524–529. 17805455
    • (2007) S Afr Med J , vol.97 , pp. 524-529
    • Rosen, S.1    Ketlhapile, M.2    Sanne, I.3    Bachman, D.S.M.4
  • 16
    • 48349136405 scopus 로고    scopus 로고
    • The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa
    • Rosen S, Long L, Sanne I, The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health. 2008;13:1005–1015. doi: 10.1111/j.1365-3156.2008.02114.x 18631314
    • (2008) Trop Med Int Health , vol.13 , pp. 1005-1015
    • Rosen, S.1    Long, L.2    Sanne, I.3
  • 17
    • 47049121281 scopus 로고    scopus 로고
    • Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa
    • Rosen S, Long L, Fox M, Sanne I, Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. J Acquir Immune Defic Syndr. 2008;48:334–344.
    • (2008) J Acquir Immune Defic Syndr , vol.48 , pp. 334-344
    • Rosen, S.1    Long, L.2    Fox, M.3    Sanne, I.4
  • 18
    • 84943161366 scopus 로고    scopus 로고
    • Aug 2008
    • Stearns BK, Evans DK, Lutung P, Wagner G, Ryan G, Aledort JE. Primary estimates of the costs of ART care at 5 AHF clinics in sub-Saharan Africa. Abstract MOPE0706. XVIIth International AIDS Conference; 3–8 Aug 2008; Mexico City, Mexico.
  • 19
    • 74049083781 scopus 로고    scopus 로고
    • Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis
    • Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, et al. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med. 2009;6:e1000189. doi: 10.1371/journal.pmed.1000189 19956658
    • (2009) PLoS Med , vol.6 , pp. e1000189
    • Leisegang, R.1    Cleary, S.2    Hislop, M.3    Davidse, A.4    Regensberg, L.5    Little, F.6
  • 21
    • 67651210831 scopus 로고    scopus 로고
    • Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G F Jooste Hospital)
    • Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S, Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G F Jooste Hospital). S Afr Med J. 2009;99:320–325. 19588792
    • (2009) S Afr Med J , vol.99 , pp. 320-325
    • Kevany, S.1    Meintjes, G.2    Rebe, K.3    Maartens, G.4    Cleary, S.5
  • 22
    • 77949542978 scopus 로고    scopus 로고
    • The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa
    • Long L, Fox M, Sanne I, Rosen S, The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS. 2010;24:915–919. doi: 10.1097/QAD.0b013e3283360976 20042849
    • (2010) AIDS , vol.24 , pp. 915-919
    • Long, L.1    Fox, M.2    Sanne, I.3    Rosen, S.4
  • 23
    • 79960925910 scopus 로고    scopus 로고
    • Treatment outcomes and cost-effectiveness of shifting management of stable ART to nurses in South Africa: an observational cohort
    • Long L, Brennan A, Fox MP, Ndibongo B, Jaffray I, Sanne I, et al. Treatment outcomes and cost-effectiveness of shifting management of stable ART to nurses in South Africa: an observational cohort. PLoS Med. 2011;8:e1001055. doi: 10.1371/journal.pmed.1001055 21811402
    • (2011) PLoS Med , vol.8 , pp. e1001055
    • Long, L.1    Brennan, A.2    Fox, M.P.3    Ndibongo, B.4    Jaffray, I.5    Sanne, I.6
  • 25
    • 84872386586 scopus 로고    scopus 로고
    • Cost and outcomes of paediatric antiretroviral treatment in South Africa
    • Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, Moultrie H, et al. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2012;27:243–250.
    • (2012) AIDS , vol.27 , pp. 243-250
    • Meyer-Rath, G.1    Brennan, A.2    Long, L.3    Ndibongo, B.4    Technau, K.5    Moultrie, H.6
  • 26
    • 85027957790 scopus 로고    scopus 로고
    • Cost and resource use of patients on antiretroviral therapy in the urban and semi-urban public sectors of South Africa
    • Meyer-Rath G, Miners A, Santos A, Variava E, Venter F, Cost and resource use of patients on antiretroviral therapy in the urban and semi-urban public sectors of South Africa. J Acquir Immune Defic Syndr. 2012;61:e25–e32. doi: 10.1097/QAI.0b013e31826cc575 22895437
    • (2012) J Acquir Immune Defic Syndr , vol.61 , pp. e25-e32
    • Meyer-Rath, G.1    Miners, A.2    Santos, A.3    Variava, E.4    Venter, F.5
  • 27
    • 85027918843 scopus 로고    scopus 로고
    • Rates and cost of hospitalisation before and after initiation of antiretroviral therapy in the urban and rural public sector of South Africa
    • Meyer-Rath G, Brennan A, Fox MP, Modisenyane T, Tshabangu N, Mohapi L, et al. Rates and cost of hospitalisation before and after initiation of antiretroviral therapy in the urban and rural public sector of South Africa. J Acquir Immune Defic Syndr. 2013;62:322–328. 23187948
    • (2013) J Acquir Immune Defic Syndr , vol.62 , pp. 322-328
    • Meyer-Rath, G.1    Brennan, A.2    Fox, M.P.3    Modisenyane, T.4    Tshabangu, N.5    Mohapi, L.6
  • 28
    • 84873549760 scopus 로고    scopus 로고
    • A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa
    • Leisegang R, Maartens G, Hislop M, Sargent J, Darkoh E, Cleary S, A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa. PLoS ONE. 2013;8:e53570. doi: 10.1371/journal.pone.0053570 23405073
    • (2013) PLoS ONE , vol.8 , pp. e53570
    • Leisegang, R.1    Maartens, G.2    Hislop, M.3    Sargent, J.4    Darkoh, E.5    Cleary, S.6
  • 29
    • 33846708321 scopus 로고    scopus 로고
    • The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa—a primary data analysis
    • Cleary S, McIntyre D, Boulle A, The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa—a primary data analysis. Cost Eff Resour Alloc. 2006;4:20. 17147833
    • (2006) Cost Eff Resour Alloc , vol.4 , pp. 20
    • Cleary, S.1    McIntyre, D.2    Boulle, A.3
  • 31
    • 28844477477 scopus 로고    scopus 로고
    • Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults
    • Bachmann MO, Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults. AIDS Care. 2006;18:109–120. 16338768
    • (2006) AIDS Care , vol.18 , pp. 109-120
    • Bachmann, M.O.1
  • 32
    • 33744791736 scopus 로고    scopus 로고
    • Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost
    • Holmes CB, Zheng H, Martinson NA, Freedberg KA, Walensky RP, Optimizing treatment for HIV-infected South African women exposed to single-dose nevirapine: balancing efficacy and cost. Clin Infect Dis. 2006;42:1772–1780. 16705586
    • (2006) Clin Infect Dis , vol.42 , pp. 1772-1780
    • Holmes, C.B.1    Zheng, H.2    Martinson, N.A.3    Freedberg, K.A.4    Walensky, R.P.5
  • 33
    • 58149097694 scopus 로고    scopus 로고
    • Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
    • Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57. doi: 10.1016/S0140-6736(08)61697-9 19038438
    • (2009) Lancet , vol.373 , pp. 48-57
    • Granich, R.M.1    Gilks, C.F.2    Dye, C.3    De Cock, K.M.4    Williams, B.G.5
  • 34
    • 77957331905 scopus 로고    scopus 로고
    • Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting
    • Cleary S, Mooney G, McIntyre D, Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting. Health Econ. 2009;19:1166–1180.
    • (2009) Health Econ , vol.19 , pp. 1166-1180
    • Cleary, S.1    Mooney, G.2    McIntyre, D.3
  • 35
    • 77954341981 scopus 로고    scopus 로고
    • Financing equitable access to antiretroviral treatment in South Africa
    • Cleary S, McIntyre D, Financing equitable access to antiretroviral treatment in South Africa. BMC Health Serv Res. 2010;10 Suppl 1:S2. doi: 10.1186/1472-6963-10-S1-S2 20594368
    • (2010) BMC Health Serv Res , vol.10 , pp. S2
    • Cleary, S.1    McIntyre, D.2
  • 37
    • 78650472932 scopus 로고    scopus 로고
    • Scaling up the 2010 World Health Organization HIV treatment guidelines in resource-limited settings: a model-based analysis
    • Walensky RP, Wood R, Ciaranello AL, Paltiel AD, Lorenzana SB, Anglaret X, et al. Scaling up the 2010 World Health Organization HIV treatment guidelines in resource-limited settings: a model-based analysis. PLoS Med. 2010;7:e1000382. doi: 10.1371/journal.pmed.1000382 21209794
    • (2010) PLoS Med , vol.7 , pp. e1000382
    • Walensky, R.P.1    Wood, R.2    Ciaranello, A.L.3    Paltiel, A.D.4    Lorenzana, S.B.5    Anglaret, X.6
  • 38
    • 77956933280 scopus 로고    scopus 로고
    • Costs of eliminating HIV in South Africa have been underestimated
    • Wagner B, Blower S, Costs of eliminating HIV in South Africa have been underestimated. Lancet. 2010;376:953. doi: 10.1016/S0140-6736(10)61442-0 20851250
    • (2010) Lancet , vol.376 , pp. 953
    • Wagner, B.1    Blower, S.2
  • 39
    • 79960604515 scopus 로고    scopus 로고
    • The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
    • Hontelez JAC, de Vlas SJ, Tanser F, Bakker R, Bärnighausen T, Newell ML, et al. The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS ONE. 2011;6:e21919. doi: 10.1371/journal.pone.0021919 21799755
    • (2011) PLoS ONE , vol.6 , pp. e21919
    • Hontelez, J.A.C.1    de Vlas, S.J.2    Tanser, F.3    Bakker, R.4    Bärnighausen, T.5    Newell, M.L.6
  • 40
    • 78650892929 scopus 로고    scopus 로고
    • Cost-effectiveness of antiretroviral regimens in the World Health Organization’s treatment guidelines: a South African analysis
    • Bendavid E, Grant P, Talbot A, Owens DK, Zolopa A, Cost-effectiveness of antiretroviral regimens in the World Health Organization’s treatment guidelines: a South African analysis. AIDS. 2011;25:211–220. doi: 10.1097/QAD.0b013e328340fdf8 21124202
    • (2011) AIDS , vol.25 , pp. 211-220
    • Bendavid, E.1    Grant, P.2    Talbot, A.3    Owens, D.K.4    Zolopa, A.5
  • 41
    • 79951480692 scopus 로고    scopus 로고
    • First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
    • Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, et al. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011;25:479–492. doi: 10.1097/QAD.0b013e3283428cbe 21293199
    • (2011) AIDS , vol.25 , pp. 479-492
    • Ciaranello, A.L.1    Lockman, S.2    Freedberg, K.A.3    Hughes, M.4    Chu, J.5    Currier, J.6
  • 42
    • 82455205791 scopus 로고    scopus 로고
    • Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study
    • Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, Cremin Í, et al. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med. 2011;8:e1001123. doi: 10.1371/journal.pmed.1001123 22110407
    • (2011) PLoS Med , vol.8 , pp. e1001123
    • Hallett, T.B.1    Baeten, J.M.2    Heffron, R.3    Barnabas, R.4    de Bruyn, G.5    Cremin, Í.6
  • 43
    • 84890844904 scopus 로고    scopus 로고
    • Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
    • Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2013;2:23–34. doi: 10.1016/S2214-109X(13)70172-4 25083415
    • (2013) Lancet Glob Health , vol.2 , pp. 23-34
    • Eaton, J.W.1    Menzies, N.A.2    Stover, J.3    Cambiano, V.4    Chindelevitch, L.5    Cori, A.6
  • 44
    • 84856920287 scopus 로고    scopus 로고
    • Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050
    • Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, et al. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050. PLoS ONE. 2012;7:e30216. doi: 10.1371/journal.pone.0030216 22348000
    • (2012) PLoS ONE , vol.7 , pp. e30216
    • Granich, R.1    Kahn, J.G.2    Bennett, R.3    Holmes, C.B.4    Garg, N.5    Serenata, C.6
  • 45
    • 84897560113 scopus 로고    scopus 로고
    • Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
    • Alistar SS, Grant PM, Bendavid E, Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa. BMC Med. 2014;12:46. doi: 10.1186/1741-7015-12-46 24629217
    • (2014) BMC Med , vol.12 , pp. 46
    • Alistar, S.S.1    Grant, P.M.2    Bendavid, E.3
  • 46
    • 38149031631 scopus 로고    scopus 로고
    • Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workers
    • Larson BA, Fox MP, Rosen S, Bii M, Sigei C, Shaffer D, et al. Early effects of antiretroviral therapy on work performance: preliminary results from a cohort study of Kenyan agricultural workers. AIDS. 2008;22:421–425. doi: 10.1097/QAD.0b013e3282f3cc0c 18195569
    • (2008) AIDS , vol.22 , pp. 421-425
    • Larson, B.A.1    Fox, M.P.2    Rosen, S.3    Bii, M.4    Sigei, C.5    Shaffer, D.6
  • 47
    • 68749103569 scopus 로고    scopus 로고
    • Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes
    • Larson BA, Fox MP, Rosen S, Bii M, Sigei C, Shaffer D, et al. Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes. BMC Public Health. 2009;9:240. doi: 10.1186/1471-2458-9-240 19604381
    • (2009) BMC Public Health , vol.9 , pp. 240
    • Larson, B.A.1    Fox, M.P.2    Rosen, S.3    Bii, M.4    Sigei, C.5    Shaffer, D.6
  • 48
    • 49549088334 scopus 로고    scopus 로고
    • The economic impact of AIDS treatment: labor supply in western Kenya
    • Thirumurthy H, Zivin JG, Goldstein M, The economic impact of AIDS treatment: labor supply in western Kenya. J Hum Resour. 2008;43:511–552. 22180664
    • (2008) J Hum Resour , vol.43 , pp. 511-552
    • Thirumurthy, H.1    Zivin, J.G.2    Goldstein, M.3
  • 49
    • 77949635883 scopus 로고    scopus 로고
    • Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya
    • Fox MP, McCoy K, Larson BA, Rosen S, Bii M, Sigei C, et al. Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya. AIDS Care. 2010;22:137–145. doi: 10.1080/09540120903038366 20390492
    • (2010) AIDS Care , vol.22 , pp. 137-145
    • Fox, M.P.1    McCoy, K.2    Larson, B.A.3    Rosen, S.4    Bii, M.5    Sigei, C.6
  • 50
    • 78049271468 scopus 로고    scopus 로고
    • The impact of HIV/AIDS and ARV treatment on worker absenteeism- implications for African firms
    • Habariyamana J, Mbakile B, Pop-Eleches C, The impact of HIV/AIDS and ARV treatment on worker absenteeism- implications for African firms. J Hum Resour. 2010;45:809–839.
    • (2010) J Hum Resour , vol.45 , pp. 809-839
    • Habariyamana, J.1    Mbakile, B.2    Pop-Eleches, C.3
  • 51
    • 33646694570 scopus 로고    scopus 로고
    • The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda
    • Marseille E, Saba J, Muyingo S, Kahn JG, The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS. 2006;20:907–914. 16549976
    • (2006) AIDS , vol.20 , pp. 907-914
    • Marseille, E.1    Saba, J.2    Muyingo, S.3    Kahn, J.G.4
  • 52
    • 84943182932 scopus 로고    scopus 로고
    • Modelling waiting times for HIV antiretroviral therapy in South Africa: patient management, outcomes and treatment rationing strategies in the Free State Province. PhD dissertation
    • Ingle SM. Modelling waiting times for HIV antiretroviral therapy in South Africa: patient management, outcomes and treatment rationing strategies in the Free State Province. PhD dissertation. University of Bristol. 2010.
    • (2010)
    • Ingle, S.M.1
  • 56
    • 84943194913 scopus 로고    scopus 로고
    • South African Reserve Bank. Repo rate. Available: http://www.resbank.co.za/Research/Rates/Pages/Repo%20Rate.aspx. Accessed 29 July 2015.
  • 57
    • 84943165516 scopus 로고    scopus 로고
    • Briggs AH, Sculpher MJ, Claxton K, Decision modelling for health economic evaluation. 1st ed. Oxford: Oxford University Press; 2006.
    • (2006)
    • Briggs, A.H.1    Sculpher, M.J.2    Claxton, K.3
  • 58
    • 84943179696 scopus 로고    scopus 로고
    • Meyer-Rath G, Brennan A, Long L, Rosen S, Fox MP. Survival in care and CD4 cell count gain on first‐line ART depend on prior CD4 cell count and time on treatment: evidence from a large South African cohort. Abstract Z-148. 17th Conference on Retroviruses and Opportunistic Infections; 16–19 February 2010; San Francisco, US.
    • (2010) , vol.16-19
    • Meyer-Rath, G.1    Brennan, A.2    Long, L.3    Rosen, S.4    Fox, M.P.5
  • 59
    • 84943194214 scopus 로고    scopus 로고
    • July 2010
    • Meyer-Rath G, Pillay Y, Blecher M, Brennan A, Long L, Johnson LF, et al: Total cost and potential cost savings of the national antiretroviral treatment (ART) programme in South Africa 2010 to 2017. Abstract WEAE0201. XVIII International AIDS Conference; 18–23 July 2010; Vienna, Austria.
    • Meyer-Rath, G.1    Pillay, Y.2    Blecher, M.3    Brennan, A.4    Long, L.5    Johnson, L.F.6
  • 60
    • 84943145068 scopus 로고    scopus 로고
    • Biggs T, Shah M. The impact of the AIDS epidemic on African firms. RPED Discussion Paper #72. Washington (District of Columbia): World Bank, Africa Region; 1997.
    • (1997)
    • Biggs, T.1    Shah, M.2
  • 61
    • 0034558486 scopus 로고    scopus 로고
    • Economic impact of HIV infection in a cohort of sugar mill workers in South Africa
    • Morris C, Burdge D, Cheevers E, Economic impact of HIV infection in a cohort of sugar mill workers in South Africa. S Afr J Econ. 2000;68:413–419.
    • (2000) S Afr J Econ , vol.68 , pp. 413-419
    • Morris, C.1    Burdge, D.2    Cheevers, E.3
  • 62
    • 0033112537 scopus 로고    scopus 로고
    • The AIDS threat and the private sector
    • Moore D, The AIDS threat and the private sector. AIDS Anal Afr. 1999;9:1–2. 12349149
    • (1999) AIDS Anal Afr , vol.9 , pp. 1-2
    • Moore, D.1
  • 63
    • 84943159011 scopus 로고    scopus 로고
    • Republic of South Africa Department of Mineral ResourcesAmendment of the broad-based socio-economic empowerment charter for the South African mining and minerals industry. Pretoria: Republic of South Africa Department of Mineral Resources; 2010.
    • (2010)
  • 64
    • 84943152740 scopus 로고    scopus 로고
    • July 2014
    • Brink B. The business case for extractive industry involvement in the fight against AIDS and TB. Abstract MOSS0302. International AIDS Conference; 20–25 July 2014; Melbourne, Australia.
    • Brink, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.